Multidisciplinary Case Conference in Psoriatic Arthritis (PsA): Enhancing Outcomes with Oral Targeted Therapies
Webcast
1 AMA PRA Category 1 Credit™ ...Faculty
OVERVIEW
Multidisciplinary Case Conference in Psoriatic Arthritis (PsA): Enhancing Outcomes with Oral Targeted Therapies is organized by i3 Health.
Dates Available:
March 17, 2026 - March 16, 2027
Statement of Need:
Psoriatic arthritis (PsA) is a chronic, immune-mediated disease that develops in up to 30% of patients with psoriasis. Characterized by inflammation of the skin, nails, entheses, and peripheral and axial joints, PsA can result in progressive joint damage, functional disability, and impaired quality of life (Kang & Coates, 2025). The advent of biologic and targeted synthetic agents directed at mediators of specific cytokine pathways—including PDE4, JAK, and TYK2—has significantly improved patient outcomes while providing the flexibility and treatment personalization potential of oral therapy (Goupille et al, 2024; Tsiogkas et al, 2025). In order to optimize the efficacy and safety of targeted therapy, multidisciplinary collaboration between members of the dermatology and rheumatology teams is crucial. In this Multidisciplinary Care Conference, Tina Bhutani-Jacques, MD, MAS, FAAD, Chief Executive Officer of Synergy Dermatology and Associate Clinical Professor at UCSF Dermatology, and Christopher Ritchlin, MD, MPH, Professor in the Division of Allergy, Immunology, and Rheumatology at the University of Rochester Medical Center, will explore strategies for enhancing outcomes with oral targeted therapies in psoriatic arthritis.
Learning Objectives:
Upon completion of this activity, participants should be able to
- Describe the role of inflammatory cytokines in the pathophysiology of PsA
- Assess risk factors, defining features, and screening tools that can enable the timely identification of PsA
- Appraise the mechanism of action, efficacy, and safety of current and emerging oral small molecule therapies for PsA
ACCREDITATION & CREDITS
Jointly Accredited Provider:
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians:
i3 Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.
Physician Assistants/Associates:
i3 Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until 3/16/27. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners:
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Nursing Continuing Professional Development:
A maximum of 1.0 ANCC contact hour may be earned by learners who successfully complete this nursing continuing professional development activity. This activity has been designated for 1.0 contact hour of pharmacology credit for Advanced Practice Registered Nurses.
Provider approved by the California Board of Registered Nursing, Provider Number 15824, for 1.0 ANCC contact hour.
TARGET AUDIENCE
PhysicianNursingDermatologistsNurse PractitionersRheumatologistsAdvanced Practice ProvidersSPECIALITIES
RheumatologyDermatology
Download eMedEvents Mobile App
Track your CE certificates and CME requirements anytime, anywhere.
RELATED ONLINE COURSES
Quick Links